Fermer le menu

Member of Lyonbiopole

 

Development of antivirals for HIV and EBV infections. Main objective is the control of the HIV-1 reservoir allowing a functional cure with cessation of the antiretroviral therapy. The second objective is the prevention of EBV-induced post transplant lymphoproliferative diseases.

 

Strategic application domain: Human Medicine

Application market: Infectious Diseases, Oncology

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Others

Created on feb. 4th, 2021 - 2 employees

 

Address

321 avenue Tony Garnier 69007 Lyon

 

Contacts

Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.